Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.024 USD | +4.35% |
|
+6.67% | +9.09% |
04-15 | Cell MedX Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
03-12 | Cell MedX Corp. announced that it has received $0.075 million in funding | CI |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
6.84M | - | - | - | - | - | |
44.87B | - | |||||
37.8B | ||||||
37.61B | ||||||
31.32B | - | |||||
27.4B |
- Stock Market
- Equities
- CMXC Stock
- Charts Cell MedX Corp.
- Sector Chart